FinalSpark is the most operationally distinctive biocomputing company, having built the only remotely accessible organoid computing platform with a subscriber base across ten universities. Its differentiation lies in infrastructure democratization rather than proprietary science, making it closer to cloud-lab infrastructure for wetware research than a product company with defined clinical or commercial endpoints.